Suchergebnisse - (Person:"Hughes, Diarmaid")

PubPharm (122)

1

Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2024

von Huseby, D. | Cao, S. | Zamaratski, E. | +29

2

Impact of Bariatric Surgery on Left Ventricular Structure and Function

enthalten in: Journal of the American Heart Association | 2024

von Hughes, D. | Aminian, A. | Tu, C. | +10

3

Apramycin efficacy in the treatment of carbapenem-resistantEnterobacteralesin murine blood stream infection models

enthalten in: bioRxiv.org | 2023

von Frimodt-Møller, N. | Hansen, J. | Plattner, M. | +10

4

New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus

enthalten in: Journal of medicinal chemistry | 2023

von Durcik, M. | Cotman, A. | Toplak, �. | +37

5

Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa

enthalten in: Journal of medicinal chemistry | 2023

von Cotman, A. | Durcik, M. | Benedetto Tiz, D. | +35

6

Dynamic Pulmonary Vein Stenosis-Utility of Multimodality Imaging and Invasive Assessment

enthalten in: Circulation. Cardiovascular imaging | 2022

von Akintoye, E. | Renapurkar, R. | Hughes, D. | +2

7

Joint antibiotic and phage therapy: addressing the limitations of a seemingly ideal phage for treatingStaphylococcus aureusinfections

enthalten in: bioRxiv.org | 2022

von Berryhill, B. | Huseby, D. | McCall, I. | +2

8

LPXH INHIBITORS AS ANTI-INFECTIVE AGENTS

enthalten in: Europäisches Patentamt | 2022

von ZAMARATSKI EDOUARD | ANTONOV DMITRY | KONDA VIVEKANANDA R | +10

9

Effect of a Run-In Period on Estimated Treatment Effects in Cardiovascular Randomized Clinical Trials : A Meta-Analytic Review

enthalten in: Journal of the American Heart Association | 2022

von Murphy, R. | O'Donnell, M. | Nolan, A. | +13

10

Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Aranzana-Climent, V. | Hughes, D. | Cao, S. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]